Availability of an Environmental Assessment for Field Testing of a Vaccine for Use Against Canine Lymphoma, 37557-37558 [2017-16977]
Download as PDF
37557
Notices
Federal Register
Vol. 82, No. 154
Friday, August 11, 2017
This section of the FEDERAL REGISTER
contains documents other than rules or
proposed rules that are applicable to the
public. Notices of hearings and investigations,
committee meetings, agency decisions and
rulings, delegations of authority, filing of
petitions and applications and agency
statements of organization and functions are
examples of documents appearing in this
section.
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2017–0054]
Availability of an Environmental
Assessment for Field Testing of a
Vaccine for Use Against Canine
Lymphoma
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of availability.
AGENCY:
We are advising the public
that the Animal and Plant Health
Inspection Service has prepared an
environmental assessment concerning
authorization to ship for the purposes of
field testing, and then to field test, an
unlicensed Canine Lymphoma Vaccine,
Live Listeria Vector. Based on the
environmental assessment, risk analysis,
and other relevant data, we have
reached a preliminary determination
that field testing this veterinary vaccine
will not have a significant impact on the
quality of the human environment. We
are making the documents available to
the public for review and comment.
DATES: We will consider all comments
that we receive on or before September
11, 2017.
ADDRESSES: You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/#!docket
Detail;D=APHIS-2017-0054.
• Postal Mail/Commercial Delivery:
Send your comment to Docket No.
APHIS–2017–0054, Regulatory Analysis
and Development, PPD, APHIS, Station
3A–03.8, 4700 River Road Unit 118,
Riverdale, MD 20737–1238.
Supporting documents and any
comments we receive on this docket
may be viewed at https://
www.regulations.gov/#!docketDetail;D=
APHIS-2017-0054 or in our reading
room, which is located in room 1141 of
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
the USDA South Building, 14th Street
and Independence Avenue SW.,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 7997039 before coming.
FOR FURTHER INFORMATION CONTACT: Dr.
Donna Malloy, Operational Support
Section, Center for Veterinary Biologics,
Policy, Evaluation, and Licensing, VS,
APHIS, 4700 River Road Unit 148,
Riverdale, MD 20737–1231; phone (301)
851–3426, fax (301) 734–4314.
For information regarding the
environmental assessment or the risk
analysis, or to request a copy of the
environmental assessment (as well as
the risk analysis with confidential
business information redacted), contact
Dr. Patricia L. Foley, Risk Manager,
Center for Veterinary Biologics, Policy,
Evaluation, and Licensing, VS, APHIS,
1920 Dayton Avenue, P.O. Box 844,
Ames, IA 50010; phone (515) 337–6100,
fax (515) 337–6120.
SUPPLEMENTARY INFORMATION: Under the
Virus-Serum-Toxin Act (21 U.S.C. 151
et seq.), the Animal and Plant Health
Inspection Service (APHIS) is
authorized to promulgate regulations
designed to ensure that veterinary
biological products are pure, safe,
potent, and efficacious before a
veterinary biological product license
may be issued. Veterinary biological
products include viruses, serums,
toxins, and analogous products of
natural or synthetic origin, such as
vaccines, antitoxins, or the immunizing
components of microorganisms
intended for the diagnosis, treatment, or
prevention of diseases in domestic
animals.
APHIS issues licenses to qualified
establishments that produce veterinary
biological products and issues permits
to importers of such products. APHIS
also enforces requirements concerning
production, packaging, labeling, and
shipping of these products and sets
standards for the testing of these
products. Regulations concerning
veterinary biological products are
contained in 9 CFR parts 101 to 124.
A field test is generally necessary to
satisfy pre-licensing requirements for
veterinary biological products. Prior to
conducting a field test on an unlicensed
product, an applicant must obtain
approval from APHIS, as well as obtain
PO 00000
Frm 00001
Fmt 4703
Sfmt 4703
APHIS’ authorization to ship the
product for field testing.
To determine whether to authorize
shipment and grant approval for the
field testing of the unlicensed product
referenced in this notice, APHIS
considers the potential effects of this
product on the safety of animals, public
health, and the environment. Based
upon a risk analysis and other relevant
data, APHIS has prepared an
environmental assessment (EA)
concerning the field testing of the
following unlicensed veterinary
biological product:
Requester: Antelope Valley Bios, Inc.
Product: Canine Lymphoma Vaccine,
Live Listeria Vector.
Possible Field Test Locations:
Arizona, California, Connecticut,
Delaware, Kansas, Maryland,
Massachusetts, Missouri, Nevada, New
Jersey, New Mexico, New York,
Pennsylvania, Rhode Island, and Texas.
This list of possible field test
locations includes States with
veterinary clinics or oncology centers
that will treat dogs, as well as States
with resident dogs that receive
treatment in another State then return
home.
The above-mentioned product
consists of a highly attenuated Listeria
monocytogenes strain that expresses a
human survivin fusion protein. It
induces a strong cell-mediated immune
response as an aid in the treatment of
dogs with lymphomas. It will be
administered only in a veterinary clinic
or veterinary oncology center by trained
personnel.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provisions
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
We are publishing this notice to
inform the public that we will accept
written comments regarding the EA
from interested or affected persons for a
period of 30 days from the date of this
notice. Unless substantial issues with
adverse environmental impacts are
raised in response to this notice, APHIS
intends to issue a finding of no
E:\FR\FM\11AUN1.SGM
11AUN1
37558
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
significant impact (FONSI) based on the
EA and authorize shipment of the above
product for the initiation of field tests
following the close of the comment
period for this notice.
Because the issues raised by field
testing and by issuance of a license are
identical, APHIS has concluded that the
EA that is generated for field testing
would also be applicable to the
proposed licensing action. Provided that
the field test data support the
conclusions of the original EA and the
issuance of a FONSI, APHIS does not
intend to issue a separate EA and FONSI
to support the issuance of the associated
product license, and would determine
that an environmental impact statement
need not be prepared. APHIS intends to
issue a veterinary biological product
license for this vaccine following
satisfactory completion of the field test,
provided no adverse impacts on the
human environment are identified and
provided the product meets all other
requirements for licensing.
Authority: 21 U.S.C. 151–159.
Done in Washington, DC, this 7th day of
August 2017.
Michael C. Gregoire,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 2017–16977 Filed 8–10–17; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF AGRICULTURE
Forest Service
Notice of Proposed New Fee Sites
Chequamegon-Nicolet National
Forest, Forest Service, Department of
Agriculture.
ACTION: Notice of Proposed New Fee
Sites.
AGENCY:
The Chequamegon-Nicolet
National Forest is proposing new
recreation fee sites. The ChequamegonNicolet’s proposal includes: A $75
nightly fee for the Franklin Lake
Caretaker Cabin, and adding nine dayuse sites to the Forest’s day-use fee
program. Sites proposed are: Ada Lake
Beach, Bear Lake Beach, Bear Lake Boat
Landing, Beck Road Trailhead, Block
House Boat Landing, Gordon Lake
Beach, Mondeaux Pines Picnic Site,
Smith Rapids Picnic Area and Wanoka
Trailhead.
Fees are assessed based on the level
of amenities and services provided, cost
of operations and maintenance and
market assessment. These fees are
proposed and will be determined upon
further analysis and public comment.
Funds from fees would be used for the
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
continued operation and maintenance
and improvements to the facilities
within the recreation areas.
An analysis of nearby recreation
facilities with similar amenities shows
that the proposed fees are reasonable
and typical of similar sites in the area.
DATES: Comments will be accepted
through September 5. New fees would
begin May 2018.
ADDRESSES: Paul I.V. Strong, Forest
Supervisor, Chequamegon-Nicolet
National Forest, 500 Hanson Lake Road
Rhinelander, WI 54501
FOR FURTHER INFORMATION CONTACT:
Hilary Markin, Public Affairs Officer,
715–362–1354. Information about these
and other proposed fee changes can also
be found on the Chequamegon-Nicolet
National Forest Web site: https://
www.fs.usda.gov/CNNF
SUPPLEMENTARY INFORMATION: The
Federal Recreation Lands Enhancement
Act (Title VII, P.L. 108–447) directed the
Secretary of Agriculture to publish a six
month advance notice in the Federal
Register whenever new recreation fee
areas are established.
All proposed day-use sites have the
six amenities required under the Federal
Lands Recreation Enhancement Act and
are similar to other fee sites on the
Chequamegon-Nicolet National Forest.
Franklin Lake Caretakers Cabin is a
unique overnight opportunity not
provided elsewhere on the forest. These
proposed new fees are part of a larger
fee proposal that includes campground
increases and a change in the price of
the annual day-use fee. For more
information on these sites and the full
proposal, visit https://www.fs.usda.gov/
CNNF/.
Dated: July 18, 2017.
Jeanne M. Higgins,
Acting Associate Deputy Chief, National
Forest System.
[FR Doc. 2017–16941 Filed 8–10–17; 8:45 am]
BILLING CODE 3411–15–P
DEPARTMENT OF AGRICULTURE
Forest Service
Nevada and Placer Counties Resource
Advisory Committee
Forest Service, USDA.
Notice of meeting.
AGENCY:
ACTION:
The Nevada and Placer
Counties Resource Advisory Committee
(RAC) will meet in Truckee, California.
The committee is authorized under the
Secure Rural Schools and Community
Self-Determination Act of 2000 (the Act)
and operates in compliance with the
SUMMARY:
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
Federal Advisory Committee Act. The
purpose of the committee is to improve
collaborative relationships and to
provide advice and recommendations to
the Forest Service concerning projects
and funding consistent with Title II of
the Act. RAC information can be found
at the following Web site: https://
cloudapps-usda-gov.force.com/FSSRS/
RAC_Page?id=001t0000002JcwUAAS.
DATES: The meeting will be held on
Thursday, August 24, 2017, at 9:00 a.m.
All RAC meetings are subject to
cancellation. For status of meeting prior
to attendance, please contact the person
listed under FOR FURTHER INFORMATION
CONTACT.
The meeting will be held at
the Truckee Ranger Station, Conference
Room, 10811 Stockrest Springs Road,
Truckee, California.
Written comments may be submitted
as described under SUPPLEMENTARY
INFORMATION. All comments, including
names and addresses when provided,
are placed in the record and are
available for public inspection and
copying. The public may inspect
comments received at Truckee Ranger
Station.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Michael Woodbridge, RAC Coordinator,
by phone at 530–478–6205 or via email
at mjwoodbridge@fs.fed.us.
Individuals who use
telecommunication devices for the deaf
(TDD) may call the Federal Information
Relay Service (FIRS) at 1–800–877–8339
between 8:00 a.m. and 8:00 p.m.,
Eastern Standard Time, Monday
through Friday.
SUPPLEMENTARY INFORMATION: The
purpose of the meeting is to:
1. Welcome and oriententation of
members,
2. Federal Advisory Committee Act
overview,
3. Development of project ranking
citeria and voting process,
4. Elect a RAC chairperson,
5. Project proponent presentations,
and
6. Review and selection of project
proposals.
The meeting is open to the public.
The agenda will include time for people
to make oral statements of three minutes
or less. Individuals wishing to make an
oral statement should submit a request
in writing at least one week prior to the
meeting to be scheduled on the agenda.
Anyone who would like to bring related
matters to the attention of the committee
may file written statements with the
committee staff before or after the
meeting. Written comments and
requests for time to make oral comments
E:\FR\FM\11AUN1.SGM
11AUN1
Agencies
[Federal Register Volume 82, Number 154 (Friday, August 11, 2017)]
[Notices]
[Pages 37557-37558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16977]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 /
Notices
[[Page 37557]]
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. APHIS-2017-0054]
Availability of an Environmental Assessment for Field Testing of
a Vaccine for Use Against Canine Lymphoma
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared an environmental assessment concerning
authorization to ship for the purposes of field testing, and then to
field test, an unlicensed Canine Lymphoma Vaccine, Live Listeria
Vector. Based on the environmental assessment, risk analysis, and other
relevant data, we have reached a preliminary determination that field
testing this veterinary vaccine will not have a significant impact on
the quality of the human environment. We are making the documents
available to the public for review and comment.
DATES: We will consider all comments that we receive on or before
September 11, 2017.
ADDRESSES: You may submit comments by either of the following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov/#!docketDetail;D=APHIS-2017-0054.
Postal Mail/Commercial Delivery: Send your comment to
Docket No. APHIS-2017-0054, Regulatory Analysis and Development, PPD,
APHIS, Station 3A-03.8, 4700 River Road Unit 118, Riverdale, MD 20737-
1238.
Supporting documents and any comments we receive on this docket may
be viewed at https://www.regulations.gov/#!docketDetail;D=APHIS-2017-
0054 or in our reading room, which is located in room 1141 of the USDA
South Building, 14th Street and Independence Avenue SW., Washington,
DC. Normal reading room hours are 8 a.m. to 4:30 p.m., Monday through
Friday, except holidays. To be sure someone is there to help you,
please call (202) 7997039 before coming.
FOR FURTHER INFORMATION CONTACT: Dr. Donna Malloy, Operational Support
Section, Center for Veterinary Biologics, Policy, Evaluation, and
Licensing, VS, APHIS, 4700 River Road Unit 148, Riverdale, MD 20737-
1231; phone (301) 851-3426, fax (301) 734-4314.
For information regarding the environmental assessment or the risk
analysis, or to request a copy of the environmental assessment (as well
as the risk analysis with confidential business information redacted),
contact Dr. Patricia L. Foley, Risk Manager, Center for Veterinary
Biologics, Policy, Evaluation, and Licensing, VS, APHIS, 1920 Dayton
Avenue, P.O. Box 844, Ames, IA 50010; phone (515) 337-6100, fax (515)
337-6120.
SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C.
151 et seq.), the Animal and Plant Health Inspection Service (APHIS) is
authorized to promulgate regulations designed to ensure that veterinary
biological products are pure, safe, potent, and efficacious before a
veterinary biological product license may be issued. Veterinary
biological products include viruses, serums, toxins, and analogous
products of natural or synthetic origin, such as vaccines, antitoxins,
or the immunizing components of microorganisms intended for the
diagnosis, treatment, or prevention of diseases in domestic animals.
APHIS issues licenses to qualified establishments that produce
veterinary biological products and issues permits to importers of such
products. APHIS also enforces requirements concerning production,
packaging, labeling, and shipping of these products and sets standards
for the testing of these products. Regulations concerning veterinary
biological products are contained in 9 CFR parts 101 to 124.
A field test is generally necessary to satisfy pre-licensing
requirements for veterinary biological products. Prior to conducting a
field test on an unlicensed product, an applicant must obtain approval
from APHIS, as well as obtain APHIS' authorization to ship the product
for field testing.
To determine whether to authorize shipment and grant approval for
the field testing of the unlicensed product referenced in this notice,
APHIS considers the potential effects of this product on the safety of
animals, public health, and the environment. Based upon a risk analysis
and other relevant data, APHIS has prepared an environmental assessment
(EA) concerning the field testing of the following unlicensed
veterinary biological product:
Requester: Antelope Valley Bios, Inc.
Product: Canine Lymphoma Vaccine, Live Listeria Vector.
Possible Field Test Locations: Arizona, California, Connecticut,
Delaware, Kansas, Maryland, Massachusetts, Missouri, Nevada, New
Jersey, New Mexico, New York, Pennsylvania, Rhode Island, and Texas.
This list of possible field test locations includes States with
veterinary clinics or oncology centers that will treat dogs, as well as
States with resident dogs that receive treatment in another State then
return home.
The above-mentioned product consists of a highly attenuated
Listeria monocytogenes strain that expresses a human survivin fusion
protein. It induces a strong cell-mediated immune response as an aid in
the treatment of dogs with lymphomas. It will be administered only in a
veterinary clinic or veterinary oncology center by trained personnel.
The EA has been prepared in accordance with: (1) The National
Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on Environmental Quality for
implementing the procedural provisions of NEPA (40 CFR parts 1500-
1508), (3) USDA regulations implementing NEPA (7 CFR part 1b), and (4)
APHIS' NEPA Implementing Procedures (7 CFR part 372).
We are publishing this notice to inform the public that we will
accept written comments regarding the EA from interested or affected
persons for a period of 30 days from the date of this notice. Unless
substantial issues with adverse environmental impacts are raised in
response to this notice, APHIS intends to issue a finding of no
[[Page 37558]]
significant impact (FONSI) based on the EA and authorize shipment of
the above product for the initiation of field tests following the close
of the comment period for this notice.
Because the issues raised by field testing and by issuance of a
license are identical, APHIS has concluded that the EA that is
generated for field testing would also be applicable to the proposed
licensing action. Provided that the field test data support the
conclusions of the original EA and the issuance of a FONSI, APHIS does
not intend to issue a separate EA and FONSI to support the issuance of
the associated product license, and would determine that an
environmental impact statement need not be prepared. APHIS intends to
issue a veterinary biological product license for this vaccine
following satisfactory completion of the field test, provided no
adverse impacts on the human environment are identified and provided
the product meets all other requirements for licensing.
Authority: 21 U.S.C. 151-159.
Done in Washington, DC, this 7th day of August 2017.
Michael C. Gregoire,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 2017-16977 Filed 8-10-17; 8:45 am]
BILLING CODE 3410-34-P